Outcomes of Surgical Intervention Following Preventive Mastectomy in BRCA1/2 Mutation Carriers

Overview

This nationwide Swedish cohort study evaluated surgical outcomes after risk-reducing mastectomy (RRM) in women with BRCA1/2 germline pathogenic variants. The study analyzed breast cancer incidence, mastectomy and reconstruction techniques, and postoperative complications, demonstrating low breast cancer occurrence post-RRM and comparable oncologic safety of skin- and nipple-sparing mastectomies.

Background

Breast cancer constitutes 25% of cancer cases among women, with BRCA1/2 germline pathogenic variants accounting for approximately 2.4% of all breast cancers. Women with BRCA1/2 mutations face high lifetime risks of breast and ovarian cancers, prompting guidelines recommending intensified surveillance and risk-reducing surgeries, including mastectomy and salpingo-oophorectomy. Risk-reducing mastectomy (RRM) can reduce breast cancer incidence by over 90%, but the extent of tissue resection and choice of mastectomy technique remain debated due to concerns about residual breast tissue and oncologic safety. This study aimed to assess long-term surgical outcomes and safety of RRM in this high-risk population.

Data Highlights

Key Findings

• Bilateral risk-reducing mastectomy (RRM) reduces breast cancer incidence by over 90% in BRCA1/2 mutation carriers.
• Primary breast cancer after bilateral RRM occurred in approximately 1.9% of women during 3 to 14 years of follow-up.
• Skin-sparing mastectomy (SSM) and nipple-sparing mastectomy (NSM) techniques allow immediate breast reconstruction with comparable oncologic safety to simple mastectomy.
• Concerns about residual breast tissue in skin flaps or nipple-areolar complex have not translated into increased long-term breast cancer risk after SSM or NSM.
• Major surgical postoperative complications were defined by bleeding, wound, infectious, or unspecified complications requiring intervention or readmission within 30 days.
• The study utilized comprehensive national registries ensuring robust data linkage and follow-up.

Clinical Implications

Risk-reducing mastectomy is an effective preventive strategy for women with BRCA1/2 mutations, significantly lowering breast cancer risk. Skin- and nipple-sparing mastectomy techniques can be safely offered to facilitate immediate reconstruction without compromising oncologic outcomes. Clinicians should counsel patients on the low but present risk of primary breast cancer post-RRM and monitor for surgical complications within the early postoperative period.

Conclusion

This large, register-based cohort study confirms that risk-reducing mastectomy, including skin- and nipple-sparing approaches, provides substantial breast cancer risk reduction with acceptable surgical safety in BRCA1/2 mutation carriers. These findings support current guidelines advocating RRM as a key preventive option in this high-risk population.

References

1. Swedish Cancer Genetic Units et al. -- Outcomes of Surgical Intervention Following Preventive Mastectomy in BRCA1 and BRCA2 Mutation Carriers